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Background
Oxidative damage has been suggested to play a role in
dementia [1,2]. The purpose of the study was to investi-
gate possible implications of lipid peroxidation in cogni-
tive impairment by determining the levels of plasma 8-
iso-PGF2α in elderly individuals with dementia.
Materials and methods
37 subjects over 60 years of age with dementia and 33
matched controls were randomly selected from a popula-
tion in the community after screening with the MMSE and
application of the diagnostic criteria of the DSM-IV.
Plasma concentrations of 8-iso-PGF2α were measured in
both groups.
Results
Demented individuals had significantly higher mean
(±SD) 8-iso-PGF2α levels compared to healthy controls
(237.44 ± 187.44 pg/ml vs 97.64 ± 42.72 pg/ml, respec-
tively, p< 0.05).
Conclusions
This study indicates an association between increased lev-
els of plasma 8-iso-PGF2α and cognitive impairment in
the elderly and indicates the necessity for further investi-
gation of oxidative stress and lipid peroxidation in
dementia, rendering isoprostanes as plausible biochemi-
cal markers of the disease in peripheral blood.
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